Filter By

Recent Articles

Dr. Chamberlain (far right) serves as session chair  with (from left) Gary Gibbons, MD, Joni Rutter, PhD, Amy Jenkins, PhD, and Amir Tamiz, PhD.

Bridging the Gap: Why Translational Research is Key to Unlocking Cell & Gene Therapy Innovation

Jeffrey S. Chamberlain, PhD | July 22, 2024

Dr. Chamberlain recapped an Annual Meeting fireside chat, "Supporting Translational Science and Transformative Therapies." If you attended the meeting, watch it on demand through Aug. 1!

Annual Meeting 2024
Read Full Story

New Policy Summit Speakers: Global Regulators Will Talk Convergence Efforts for CGTs

Join us Sept. 23-24 at the Westin Washington DC Downtown Hotel or virtually! | July 22, 2024

Presenters from regulatory agencies in Spain, Japan, and the United States will discuss considerations for earlier approval pathways and how their agencies are thinking about CGT regulation into the future.

Policy & Advocacy
Read Full Story

CRISPR and Beyond with Vertex CSO David Altshuler, MD, PhD—ASGCT's The Issue

Listen to The Issue now! | July 16, 2024

David and Emily discuss how David and the team at Vertex think about innovation in drug development and how that impacts how they select programs and approaches for the diseases they focus on.

Read Full Story

Magdalena Lyimo, MD, MMed, PhD is the Head of the Department of Hematology and Blood Transfusion at Muhimbili University of Health and Allied Sciences in Tanzania.  

First Time Attendee Experience at the Annual Meeting

Magdalena Lyimo, MD, MMed, PhD | July 11, 2024

In 2023, I completed the Global Gene Therapy Training course which is offered by ASGCT in collaboration with the Muhimbili University of Health and Allied Sciences, Tanzania.

Read Full Story

Volunteer Spotlight: Allison M. Bradbury, PhD

July 11, 2024

The Bradbury Laboratory is dedicated to understanding disease mechanisms and the development of safe and efficient therapeutic approaches for rare, pediatric neurologic disorders. 

Volunteer Spotlight
Read Full Story

Targeting STAT3 in Tumors with Oligo-PROTAC with Dr. Marcin Kortylewski

Listen to this episode of The Molecular Therapy Podcast | July 09, 2024

If you enjoy today’s conversation, you’ll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, September 23-24. 

Read Full Story

July 19: Abstract Deadline Extended for Advancing Gene + Cell Therapies for Cancer

Send us your research for the chance to present it this fall. | June 28, 2024

Send us your research for the chance to present it at the event this fall.

Read Full Story

AAV Capsid Production with Drs. Mario Mietzsch and Robert McKenna

Molecular Therapy Podcast | June 18, 2024

Listen today on the ASGCT Podcast Network!

Molecular Therapy  |  Podcasts
Read Full Story

Maria Santaella, PhD (c), MSN, RN-BC, CPHON serves as the Vice President of Research for the National Bleeding Disorders Foundation. During the workshop she spoke on clinical trial enrollment by sharing strategies to address barriers in recruiting.

Inclusive Trial Design Amplifies Patient Voices and Drives Meaningful Outcomes

Samuel Hughes, MBA, St. Jude Children's Research Hospital | June 18, 2024

Overcoming recruitment, endpoint, and resource challenges in rare disease trials was the focus of the workshop organized by the Patient Outreach Committee at the ASGCT 27th Annual Meeting.

Annual Meeting 2024  |  Outreach  |  Patient Perspectives  |  Policy & Advocacy
Read Full Story

Patient Advocates Connect at the Annual Meeting

Ali Kujawski, Senior Patient Outreach Manager | June 12, 2024

Patient advocates connected, learned from researchers, and shared experiences at ASGCT's 2nd Annual Patient Advocate Connection Luncheon, hosted at the ASGCT Annual Meeting, highlighting the Society's commitment to engaging the patient community.

Annual Meeting 2024  |  Policy & Advocacy
Read Full Story

Gene Insertion Tech with SalioGen CEO Jason Cole

ASGCT Podcast Network | June 11, 2024

SalioGen CEO Jason Cole joins host Emily Walsh Martin, PhD to explore the company's cutting-edge transposase-based gene insertion technology presented at the ASGCT Annual Meeting.

Read Full Story

Meet Catherine Gillespie: ASGCT Volunteer Spotlight

Dani Gale | June 04, 2024

Catherine Gillespie's passion for language and storytelling led her to the forefront of gene and cell therapy communications at ASGCT.

Volunteer Spotlight
Read Full Story

A New Vision for MTMCD with EiC Dr. Mohamed Abou-el-Enein

ASGCT Podcast Network | June 04, 2024

Mohamed Abou-el-Enein, MD, PhD, MSPH, the new editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD), sits down with Scientific Editor Rory Bricker-Anthony, PhD, to discuss his vision for the journal.

Molecular Therapy  |  Podcasts
Read Full Story

FDA's Dr. Nicole Verdun and Julie Tierney to Speak at ASGCT's 2024 Policy Summit

Register today to hear from these influential FDA officials Sept. 23-24. | May 29, 2024

Register today to hear from these influential FDA officials Sept. 23-24.

Policy & Advocacy  |  Policy Summit
Read Full Story

ASGCT Urges Congress to Address Gene Therapy Access Hurdles

Margarita Valdez Martínez | May 24, 2024

ASGCT advocates for policies to ensure patient access to transformative cell and gene therapies, which can face coverage barriers in employer-sponsored insurance plans. Key issues include transparency around coverage decisions and flexibility to explore innovative payment models.

Policy & Advocacy
Read Full Story

ASGCT Members Lead Congressional Briefing on Gene Editing

May 24, 2024

A cohort of ASGCT members and leaders together delivered a Congressional briefing to educate the governing body on the potential for gene-edited therapies to address unmet needs.

Read Full Story

Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.